Daily Stock Market Outlook Report by Imperial Money Pvt. Ltd. of 16th Dec, 2021. Download Full Report Now!!! Nifty opened with flat to positive gap up today at 17,373 on 16th Dec 2021, index was very volatile and made a day high of 17,379.35 and closed positive at very important level 17,248.40. Resistance for nifty is 17,800 and support is 16700 (Closing Basis). Index may test 18000 in coming days.

1. MARKET OUTLOOK REPORT
Figure. Nifty50 Intraday chart
Index Previous close Open High Low Close Change %
Nifty 50 17,221.40 17,373.00 17,379.35 17,184.95 17,248.40 0.16%
Sensex 57,788.03 58,243.43 58,337.20 57,683.11 57,901.14 0.20%
Nifty opened with flat to
positive gap up today at
17,373 on 16th
Dec 2021,
index was very volatile and
made a day high of
17,379.35 and closed
positive at very important
level 17,248.40. Resistance
for nifty is 17,800 and
support is 16700 (Closing
Basis). Index may test
18000 in coming days.
www.imperialfin.com wecare@imperialfin.com +91-9595889988
16th
DEC 2021

2. Sectorial Performance
0.48%
1.18%
0.88%
0.35%
0.65%
0.73%
1.77%
0.84%
0.12%
NIFTYFMCG
NIFTYIT
NIFTYPHARMA
NIFTYFINSERVICE
NIFTYBANK
NIFTYAUTO
NIFTYMEDIA
NIFTYREALTY
NIFTYMETAL
SECTORS CHANGE %
SECTORS CHANGE %
www.imperialfin.com wecare@imperialfin.com +91-9595889988
16th
DEC 2021

3. Top Trending News
 Indigo, Kotak Mahindra Bank
IndiGo airlines has launched a co-branded credit card in partnership with Kotak Mahindra Bank.
 Tata Motors, Bandhan Bank
Tata Motors has tied up with Bandhan Bank for retail finance for its range of passenger vehicles.
 Cipla
Cipla has signed a pact to acquire a 33% stake in renewable energy firm Clean Max Auriga Power LLP for up to Rs 6 crore.
 TVS Motor Company
TVS Motor Company and BMW Motorrad have expanded their partnership to include joint development of new platforms
and future technologies.
 Tata Steel
India Ratings and Research (Ind-Ra) has upgraded Tata Steel‘s long-term issuer rating to ‘AA+’ from ‘AA’.
 Sun Pharma
Sun Pharma’s US subsidiary has received final approval from the USFDA for generic Amphotericin B Liposome injection.
It is intended to be used in treatment of fungal infections.
16th
DEC 2021
www.imperialfin.com wecare@imperialfin.com +91-9595889988

4. 2.65%
2.46% 2.40%
2.16% 2.16%
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
BAJFINANCE LTI GLAND INFY SBICARD
TOP GAINERS
6.22%
3.26%
2.57% 2.55%
1.86%
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
7.00%
BAJAJHLDNG BIOCON ADANIGREEN YESBANK GAIL
TOP LOSERS
Stocks in Action
www.imperialfin.com wecare@imperialfin.com +91-9595889988
16th
DEC 2021

5. Corporate Actions
 MIC Electronics Limited (Annual General Meeting on 17th
Dec)
 KSS Limited (Annual General Meeting on 17th
Dec)
FII/DII/FPI ACTION IN CAPITAL MARKET
Category Date Buy Value Sell Value Net Value
DII 15 Dec 2021 5721.32 cr 4168.31 cr 1553.01 cr
FII/FPI 15 Dec 2021 5373.66 cr 8780.70 cr -3407.04 cr
 The following is combined Domestic Institutional Investors trading data across NSE, BSE and MSEI
collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System.
16th
DEC 2021
www.imperialfin.com wecare@imperialfin.com +91-9595889988

6. TCS. Sector:IT.
Important Parameter
MARKET CAP P/B EPS BOOK VALUE PE ROE ROCE
13,24,852.24
CR
15.74 96.91 227.57 36.96 42.02% 56.24%
FUNDAMENTALS.
 The Company is Virtually Debt Free.
 The Company has a good ROE track record of 41.55%.
 The company has effective cash conversion ratio of 109.24.
 The Company has healthy Operating Margin of 29.65%.
Stock Entry price Positional
target
TCS 3575 4100
www.imperialfin.com wecare@imperialfin.com +91-9595889988
16th
DEC 2021

7. Disclaimer
This document has been prepared for IMPERIAL MONEY PVT. LTD. by Mr. Praveen Dubey NISM (201800048686) is a Research Consultant for Imperial Money Pvt. Ltd. This Market Outlook is
intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any
review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. Imperial Money Pvt. Ltd. Does not carry any responsibility in case to whomsoever using the information of this newsletter content and data
www.imperialfin.com wecare@imperialfin.com +91-9595889988
16th
DEC 2021